⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 1, 2024

[Clinical Analysis of PEG-rhG-CSF in Mobilization of Autologous Hematopoietic Stem Cells in Hematological Tumors].

Qingjiao Chen Xiaoqiang Zheng

View at Publisher

Ask AI

Bookmark

Share

Abstract

To investigate the efficiency and optimal time of stem cell apheresis mobilized by pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in autologous stem cell transplantation (ASCT) for hematological malignancies without monitoring pre-collection CD34

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e71600b6db64358768e87e https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.02.035

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma2025 · 1 citations
2Comparison of two autologous hematopoietic stem cell mobilization strategies in patients with multiple myeloma: <scp>CE</scp> plus <scp>G‐CSF</scp> versus <scp>G‐CSF</scp> only: A single‐center retrospective analysis2024 · 8 citations
3Etoposide + cytarabine + pegfilgrastim vs cyclophosphamide + granulocyte colony-stimulating factor for stem-cell mobilization in patients with multiple myeloma: A phase III trial2025
4Research Article: Cyclophosphamıde–Etoposıde + G-csf Compared to G-csf alone in Perıpheral Blood Stem Cell Mobılızatıon for Multıple Myeloma2022
5Fractionated Intermediate‐Dose Etoposide Plus G‐ CSF for Peripheral Blood Stem Cell Mobilization in Patients With Lymphoma and Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: A Prospective Observational StudyCohort Study · 2026

More related papers

Chinese experience in hematopoietic stem cell mobilization and collection in lymphoma patients: a retrospective cohort study2024
Plerixafor Plus Granulocyte Colony-Stimulating Factor versus Placebo Plus Granulocyte Colony-Stimulating Factor for Mobilization of CD34+ Hematopoietic Stem Cells in Patients with Multiple Myeloma and Low Peripheral Blood CD34+ Cell Count: Results of a Subset Analysis of a Randomized Trial2012
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G‐CSF mobilization2014